A British cardiologist and adviser to Health and Human Services Secretary Robert F. Kennedy Jr. told the Daily Beast that President Donald Trump’s administration is preparing to pull Covid-19 vaccines from the U.S. market “within months,” saying internal discussions are already taking place. The White House dismissed the claim as "baseless speculation," with spokesman Kush Desai insisting that any vaccine policy will be based on “gold standard science.” The Food and Drug Administration has issued no notice of action against the currently authorized shots. Kennedy has already fired all 17 members of the CDC’s vaccine advisory committee, cut $500 million in grants for mRNA-based research, and rolled back CDC recommendations for vaccinating healthy children and pregnant women—moves that public-health experts say signal a broader campaign to limit access to immunizations. Industry analysts warned that an outright market withdrawal would carry significant legal and financial risks for manufacturers such as Pfizer, BioNTech, Moderna and Novavax, whose shares were flagged on social-media trading forums after the report surfaced. The controversy follows criticism of the administration’s slow response to a West Texas measles outbreak that infected at least 762 people and killed two children, heightening concern among physicians that shifting federal policy is eroding public confidence in routine vaccinations as the school year begins.